ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) JPX
2,761.00
+44(+1.62%)
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
2,761.00
+44(+1.62%)
Currency In JPY
Address
5-1, Shibaura 2-Chome
Tokyo, 108-8532
Japan
Phone
81 3 5484 8845
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
762
First IPO Date
April 01, 2021
| Name | Title | Pay | Year Born |
| Maiko Mori | Managing Executive Officer and Director | 0 | 1964 |
| Fumiyoshi Yamaguchi | Managing Executive Officer and Director | 0 | 1986 |
| Kiyohiko Tamura | Executive Corporate Officer & Director of Group Business Management Division | 0 | N/A |
| Atsushi Maruo | Senior Managing Director & Representative Director | 0 | 1959 |
| Takashi Yamaguchi | Representative Director & Chairman of the Board | 0 | 1952 |
| Tomoyuki Hatakeyama | Director of Finance & Accounting Dept., Group Bus. Mgmt Div. and Manager of Accounting Section | 0 | N/A |
| Sohta Yamaguchi | President & Representative Director | 0 | 1983 |
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.